Why Asana Is Trading Higher By 24%; Here Are 24 Stocks Moving Premarket

Gainers

• Asana, Inc. (NYSE:ASAN) rose 24.1% to $23.62 in pre-market trading after the company reported better-than-expected results for its second quarter and issued a strong sales guidance.
• AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) shares rose 20.5% to $0.3485 in pre-market trading after gaining around 6% on Wednesday. AcelRx Pharmaceuticals, last month, posted a Q2 loss of $0.06 per share.
• Revance Therapeutics, Inc. (NASDAQ:RVNC) rose 18.4% to $24.66 in pre-market trading as the company reported the FDA approval of DAXXIFY for injection, a peptide-formulated neuromodulator with long-lasting results.
• Bright Green Corporation (NASDAQ:BGXX) rose 15.2% to $1.80 in pre-market trading as the company reported pricing of $10.0 million private placement.
• Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) shares rose 12% to $1.96 in pre-market trading after gaining over 4% on Wednesday.
• Rubius Therapeutics, Inc. (NASDAQ:RUBY) rose 11.8% to $0.9702 in pre-market trading after declining 11% on Wednesday. Rubius Therapeutics, last month, posted a Q2 loss of $0.49 per share.
• Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) rose 11% to $0.1040 in pre-market trading.
• PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) rose 10.4% to $1.17 in pre-market trading. The company, last month, posted a wider Q2 loss.
• First High-School Education Group Co., Ltd. (NYSE:FHS) rose 9.2% to $0.70 in pre-market trading.
• ShiftPixy, Inc. (NASDAQ:PIXY) rose 8.8% to $12.20 in pre-market trading after declining over 4% on Wednesday.
• Heliogen, Inc. (NYSE:HLGN) rose 8.6% to $2.40 in pre-market tradinh.
• GameStop Corp. (NYSE:GME) rose 7.4% to $25.82 in pre-market trading after the company reported better-than-expected earnings for its second quarter and also announced a partnership with cryptocurrency exchange FTX to bring more customers to the digital asset space.

Don’t forget to check out our premarket coverage here .

Losers

• Chembio Diagnostics, Inc. (NASDAQ:CEMI) shares fell 16.9% to $0.52 in pre-market trading. Chembio Diagnostics filed for potential stock offering.
• American Eagle Outfitters, Inc. (NYSE:AEO) shares fell 14.8% to $9.86 in pre-market trading after the company reported worse-than-expected Q2 EPS results.
• Dallasnews Corp (NASDAQ:DALN) fell 14.4% to $7.18 in pre-market trading. DallasNews recently announced a special dividend of $1.50 per share.
• Torrid Holdings Inc. (NYSE:CURV) fell 13.4% to $4.65 in pre-market trading after the company reported worse-than-expected Q2 EPS results. The company also issued Q3 and FY22 sales guidance below analyst estimates.
• Skillsoft Corp. (NYSE:SKIL) fell 12.6% to $2.35 in pre-market trading after the company posted downbeat quarterly sales and authorized a $30 million share buyback.
• Troika Media Group, Inc. (NASDAQ:TRKA) fell 12.3% to $0.57 in pre-market trading after declining around 6% on Wednesday.
• Wayfair Inc. (NYSE:W) fell 9.3% to $46.00 in pre-market trading after the company reported a proposed offering of $600 million convertible senior notes.
• Grid Dynamics Holdings, Inc. (NASDAQ:GDYN) fell 9.1% to $18.00 in pre-market trading after the company priced its common stock offering of about 5.71 million shares at $17.50 per share.
• HyreCar Inc. (NASDAQ:HYRE) fell 8.8% to $1.25 in pre-market trading. HyreCar shares gained around 8% on Wednesday after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.
• DBV Technologies S.A. (NASDAQ:DBVT) shares fell 7.6% to $2.08 in pre-market trading. DBV Technologies reported initiation of Phase 3 study (VITESSE) using the modified viaskin peanut patch in peanut -allergic children ages 4 to 7 years.
• Bilibili Inc. (NASDAQ:BILI) fell 6.4% to $22.10 in pre-market trading following Q2 results.
• McCormick & Company, Incorporated (NYSE:MKC) fell 6.1% to $79.83 in pre-market trading. McCormick said it expects third-quarter FY22 sales to increase about 3% year-on-year and 6% in constant currency.